Fox Run Management, L.L.C. Gsk PLC Transaction History

Fox Run Management, L.L.C.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$42.05 - $47.77 $314,786 - $357,606	7,486 New	7,486 $326,000
Q1 2022 May 10, 2022	SELL	$40.23 - $47.74 $427,564 - $507,380	-10,628 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$38.88 - $45.31 $413,216 - $481,554	10,628 New	10,628 $469,000
Q3 2021 Nov 15, 2021	SELL	$38.79 - $43.16 $269,357 - $299,703	-6,944 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$36.52 - $41.46 $253,594 - $287,898	6,944 New	6,944 $277,000
Q1 2021 May 17, 2021	SELL	$34.27 - $40.01 $288,450 - $336,764	-8,417 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$34.07 - $39.94 $286,767 - $336,174	8,417 New	8,417 $310,000
Q4 2019 Feb 14, 2020	SELL	$42.0 - $48.25 $359,646 - $413,164	-8,563 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$40.46 - $43.52 $346,458 - $372,661	8,563 New	8,563 $365,000
Q3 2018 Oct 05, 2018	SELL	$39.75 - $42.69 $208,091 - $223,482	-5,235 Closed	0 $0
Q2 2018 Jul 17, 2018	SELL	$39.61 - $42.76 $277 - $299	-7 Reduced 0.13%	5,235 $211,000
Q1 2018 Apr 17, 2018	SELL	$36.18 - $40.15 $77,678 - $86,202	-2,147 Reduced 29.06%	5,242 $205,000
Q4 2017 Jan 18, 2018	BUY	$35.34 - $41.9 $261,127 - $309,599	7,389	7,389 $262,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.